Publications en collaboration avec des chercheurs de Hospital General Universitario de Alicante (22)

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

  3. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

2022

  1. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial

    JAMA Network Open, Vol. 5, Núm. 1

  2. Frequency and characteristics of HTLV in migrants: results from the +Redivi collaborative network in Spain

    Journal of travel medicine, Vol. 29, Núm. 7

  3. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  4. Trends in imported malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network)

    Journal of travel medicine, Vol. 29, Núm. 6

2021

  1. Epidemiological and clinical profile of immunosuppressed patients with imported strongyloidiasis: a substudy from a larger cohort of the +REDIVI Spanish Collaborative Network.

    Pathogens and Global Health, Vol. 115, Núm. 2, pp. 121-124

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network

    Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57

  2. High delayed mortality after the first episode of Clostridium difficile infection

    Anaerobe, Vol. 57, pp. 93-98

  3. Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish collaborative network (2009-2017)

    PLoS Neglected Tropical Diseases, Vol. 13, Núm. 5

  4. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

  2. Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 393-398

2017

  1. Eosinophilia prevalence and related factors in travel and immigrants of the network +REDIVI

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 10, pp. 617-623

  2. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

2016

  1. Characteristics of HIV infected individuals traveling abroad. Results from the +REDIVI Collaborative Network

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 2, pp. 108-113

  2. Travelers' diarrhea in children at risk: An observational study from a Spanish database

    Pediatric Infectious Disease Journal, Vol. 35, Núm. 4, pp. 392-395